ELAN
Elanco Animal Health Inc
Key Financials
Gross Profit
$2.6B
↑ 6.4%
Revenue
$4.7B
↑ 6.2%
Net Income
$-232000000
↓ 168.6%
Total Assets
$13.4B
↑ 5.9%
EPS (Diluted)
$-0.47
↓ 169.1%
Total Liabilities
$6.8B
↑ 4.5%
Shareholders' Equity
$6.5B
↑ 7.4%
Long-term Debt
$3.8B
↓ 12.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELAN |
| Company Name | Elanco Animal Health Inc |
| CIK | 1739104 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 877-352-6261 |